Aileron Therapeutics (NASDAQ:ALRN – Get Free Report) and Atreca (NASDAQ:BCEL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk. Profitability This table compares Aileron Therapeutics and Atreca’s […]
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of antibodies and related.
Globally, private-equity buyout and growth funds raised $155.7 billion in the three months through March, while U.S.-based funds gathered $76.8 billion, research firm PitchBook Data said in a. -April 10, 2024 at 06:18 am EDT
- MarketScreener
North American Morning Briefing: Traders Await -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Atreca, Inc. (NASDAQ:BCEL) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.